The president, Joe Biden, said that cannabis is not as bad as it was thought before. He changed the rules so that people who grow or sell weed do not have to follow some very strict rules they had before. This makes them and their businesses very happy because now they can make more money and help more people with weed. People who like weed also celebrate this news, and the price of weed companies' stocks goes up a lot. Read from source...

- The headline is misleading and exaggerated. It implies that the weed industry celebrated Biden's move as a monumental cannabis reform when in reality it was just a rescheduling process that moved cannabis from Schedule I to Schedule III, which is still a very restrictive category with no medical use accepted by the federal government.
- The article uses vague and undefined terms like "most monumental cannabis reform" and "long-standing wrong". What are these exactly? How are they measured or verified? These are subjective opinions that lack factual support or clarification.
- The article quotes several executives and advocates who have a vested interest in the weed industry and its profitability. They are not impartial or unbiased sources of information. Their statements are likely influenced by their personal or professional agenda, rather than the actual impact of Biden's move on cannabis policy and consumers.
- The article mentions that rescheduling will improve the cash flow of state-legal cannabis businesses and provide federal support for state cannabis markets, but it does not explain how or why this is true. It also ignores the potential negative consequences of rescheduling, such as increased regulation, taxation, or legal risks for cannabis companies and consumers.
- The article focuses on the financial aspect of the weed industry and its stocks, rather than the social, medical, or ethical implications of Biden's move. It does not provide any data or evidence on how rescheduling will affect the availability, accessibility, safety, quality, or price of cannabis products for patients, consumers, or researchers.
- The article does not address the legal status of cannabis under international law, which may still conflict with Biden's move and create challenges for the global weed industry and trade. It also does not acknowledge the diversity of opinions and perspectives on cannabis among different groups and individuals in society.